CG Invites Co., Ltd.
A biopharmaceutical company specializing in digital genomics and personalized medicine.
083790 | KO
Overview
Corporate Details
- ISIN(s):
- KR7083790006
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강서구 마곡중앙8로 38 마곡동, 강서구
- Website:
- https://cginvites.com/en
- Sector:
- Manufacturing
Description
CG Invites Co., Ltd. is a biopharmaceutical company specializing in digital genomics and personalized medicine. The company's activities are focused on four main areas: genomics, personalized cancer vaccines, digital therapeutics, and the development of chemical and biological drugs. It utilizes Whole Genome Sequencing to support precision medicine initiatives and develops mRNA-based personalized cancer vaccines. The company also creates software-based medical interventions, known as digital therapeutics. Its drug development pipeline includes therapeutics for oncology and inflammatory diseases, such as Acelex for osteoarthritis, Ivaltinostat for pancreatic cancer, and Camrelizumab for immuno-oncology. The company's research approach is based on structural chemoproteomics and the integration of genomic data to develop targeted treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-09-18 00:00 |
증권발행결과(자율공시)
|
Korean | 5.9 KB | ||
| 2020-09-17 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 89.3 KB | ||
| 2020-09-11 00:00 |
임시주주총회결과
|
Korean | 11.0 KB | ||
| 2020-09-10 00:00 |
기업설명회(IR)개최
|
Korean | 7.4 KB | ||
| 2020-09-03 00:00 |
투자판단관련주요경영사항(코로나-19 바이러스(SARS-CoV-2)환자에 대한 Ivaltinostat와 Hydroxychloroquine 병용임…
|
Korean | 7.6 KB | ||
| 2020-08-28 00:00 |
[기재정정]의결권대리행사권유참고서류
|
Korean | 26.0 KB | ||
| 2020-08-27 00:00 |
기업설명회(IR)개최
|
Korean | 7.4 KB | ||
| 2020-08-27 00:00 |
주주총회소집공고
|
Korean | 60.9 KB | ||
| 2020-08-27 00:00 |
[기재정정]주주총회소집공고
|
Korean | 62.8 KB | ||
| 2020-08-27 00:00 |
의결권대리행사권유참고서류
|
Korean | 24.2 KB | ||
| 2020-08-27 00:00 |
[기재정정]주주총회소집결의
|
Korean | 15.9 KB | ||
| 2020-08-20 00:00 |
기타경영사항(특허권취득)(자율공시)(BTK 키나아제 억제제로서의 2,3-디하이드로-이소인돌-1-온 유도체 및 이를 함유하는 약학적 조성물)
|
Korean | 5.9 KB | ||
| 2020-08-14 00:00 |
반기보고서 (2020.06)
|
Korean | 2.3 MB | ||
| 2020-08-04 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.6 KB | ||
| 2020-07-31 00:00 |
기업설명회(IR)개최
|
Korean | 7.4 KB |
Automate Your Workflow. Get a real-time feed of all CG Invites Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for CG Invites Co., Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for CG Invites Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
